EUVIMEDEUVIMED entdecken
Crossref

A Pt( iv ) prodrug-gating MOF incorporating copper peroxide and ruthenium complex for NIR-mediated synergistic anticancer therapy

Romaine Parker, Rajeshkumar Anbazhagan, Chia-Yu Kuo, Teng-Hao Chen

Biomaterials Science · 2026

DOI: 10.1039/d5bm01557j ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomaterials Science, 2026. Verfasst von Romaine Parker und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Pharmacy and Pharmaceutical Sciences, School of Pharmacy, College of Medicine, National Cheng Kung University, Tainan City 7010…. Hauptthemen laut MEDLINE: Prodrugs, Antineoplastic Agents, Copper, Ruthenium. Die Arbeit nennt 56 Literaturangaben. Gefördert von: National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A Zr-MOF is incorporated with copper peroxide and a ruthenium complex, and these guest molecules are gated by a chemotherapeutic Pt( iv ) prodrug for controlled release and synergistic anticancer therapy upon near-infrared irradiation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsAntineoplastic AgentsCopperRutheniumMetal-Organic FrameworksPeroxidesPlatinumAnimalsInfrared RaysCell Line, TumorHumansMiceReactive Oxygen SpeciesPhotochemotherapy

Substanzen

ProdrugsAntineoplastic AgentsCopperRutheniumMetal-Organic FrameworksPeroxidesReactive Oxygen SpeciesPlatinum

Autor:innen und Institutionen

  • Institute of Clinical Pharmacy and Pharmaceutical Sciences, School of Pharmacy, College of Medicine, National Cheng Kung University, Tainan City 70101, Taiwan. thchen@gs.ncku.edu.tw.

Förderung

  • National Science and Technology Council

Zitieren

APA

Parker, R., Anbazhagan, R., Kuo, C. Y., & Chen, T. H. (2026). A Pt( iv ) prodrug-gating MOF incorporating copper peroxide and ruthenium complex for NIR-mediated synergistic anticancer therapy. Biomaterials Science. https://doi.org/10.1039/d5bm01557j

Vancouver

Parker R, Anbazhagan R, Kuo CY, Chen TH. A Pt( iv ) prodrug-gating MOF incorporating copper peroxide and ruthenium complex for NIR-mediated synergistic anticancer therapy. Biomaterials Science. 2026. doi:10.1039/d5bm01557j

BibTeX
@article{Parker2026,
  author = {Parker, Romaine and Anbazhagan, Rajeshkumar and Kuo, Chia-Yu and Chen, Teng-Hao},
  title = {A Pt( iv ) prodrug-gating MOF incorporating copper peroxide and ruthenium complex for NIR-mediated synergistic anticancer therapy},
  journal = {Biomaterials Science},
  year = {2026},
  doi = {10.1039/d5bm01557j}
}
Kostenlos starten →